Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380049 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL379519 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL15229291 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL719001 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| Ocrylate SCHEMBL29891 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL2903638 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL29340 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL35540 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL3457991 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL7744948 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | claimed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| US-20250215132-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2025-07-03 | — | — | US | claimed |
| EP-3579890-B1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES | FEMASYS INC (US) | 2025-06-18 | — | — | EP | claimed |
| EP-4504844-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2025-02-12 | — | — | EP | claimed |
| US-20240240064-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2024-07-18 | — | — | US | claimed |
| EP-4334368-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2024-03-13 | — | — | EP | claimed |
| CN-117377706-A | Two-part curable composition | 博斯蒂克股份公司 | 2024-01-09 | — | — | CN | claimed |
| US-20230390105-A1 | METHODS AND DEVICES FOR CONTROLLED DELIVERY | POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC | 2023-12-07 | — | — | US | claimed |
| US-20040254561-A1 | Dual-ended applicator for dispensing two fluids | ADVANCED MEDICAL SOLUTIONS (PLYMOUTH) LIMITED (GB) | 2004-12-16 | — | — | US | claimed |
| EP-1455738-A2 | USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT | L'OREAL (FR) | 2004-09-15 | — | — | EP | claimed |
| US-20030175229-A1 | Electrophilic monomers for treating the hair | L'OREAL (FR) | 2003-09-18 | — | — | US | claimed |
| WO-2003053380-A2 | USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT | L'OREAL (FR) | 2003-07-03 | — | — | WO | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| EP-0824316-A4 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 2001-01-17 | — | — | EP | claimed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | claimed |
| EP-0824316-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Nielsen, Thor, B. (US) | 1998-02-25 | — | — | EP | claimed |
| WO-1996034526-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 1996-11-07 | — | — | WO | claimed |
| US-4393183-A | STORAGE STABILITY, BONDING STRENGTH | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-07-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254561-A1 | Dual-ended applicator for dispensing two fluids | ADIPOR2, ARID2, EPCAM | TSHR 1411/4885ALDH1A1 186/4885NAAA 2192/4885 |
| US-20030175229-A1 | Electrophilic monomers for treating the hair | NACA, SUCLG1, TYR | TSHR 4584/4885ALDH1A1 176/4885NAAA 219/4885 |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | TSHR 148/4885ALDH1A1 3677/4885NAAA 931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.